The “glycemic index” refers to how much 50 grams of carbohydrates raise blood glucose, depending on the specific food eaten. There is plenty of evidence that a low glycemic index diet helps in prevention and treatment of diabetes. However, there has been limited data on how lower and higher glycemic index foods affect risk for […]
People who have type 2 diabetes often have reduced muscle strength, with the ability of the muscles to take up glucose impaired. Researchers have found that a particular gene that normally plays an important role in muscle regeneration is “silenced” in people who have type 2 diabetes. The discovery may lead to future new treatments. […]
Heart disease risk increases with age. Researchers examining the impact of diabetes and high blood pressure on heart disease risk as people grow older found that each measured increase in systolic blood pressure was associated with an increased risk of cardiovascular diseases. The risk was even higher when the patient also had diabetes. Read more
Women who experienced gestational diabetes during their pregnancies would welcome support in helping them maintain a healthy diet and do more physical activity after pregnancy in order to reduce future diabetes risk, a study in the United Kingdom found. Read more
A study in Germany found that children with a new diagnosis of type 1 diabetes experienced higher rates of diabetic ketoacidosis (DKA), a dangerous complication of diabetes, during the COVID-19 pandemic. Read more
People who have mental illness along with diabetes may struggle when it comes to diabetes self-care and management. The authors of a new study investigating the impact of severe mental illness on adults with diabetes say better interventions and support are needed to help these adults cope with their diabetes needs. Read more
Researchers studying gut bacterial were able to isolate four different types of bacteria responsible for either increasing or decreasing the negative impact that can be caused by a typical American diet. The researchers found that patients with diabetes may benefit from adding foods that contain a particular gut bacteria to their diets. Read more
Diabetes patients who are older, who have had the disease for at least 10 years, and/or have high glycated hemoglobin (A1C), are likely to have damage to corneal endothelial cells, researchers say. The results support the need for patients with diabetes to have regularly-scheduled corneal endothelial examinations. Read more
A recent study says that the access of people with type 2 diabetes to sodium-glucose cotransporter 2 (SGLT2) inhibitor treatment has significant ethnic, gender and socioeconomic disparities, with women, Black or Asian patients less likely to receive SGLT-2 inhibitor treatment. Read more
Four members of Congress have introduced the Promoting Responsible and Effective Virtual Experiences through Novel Technology to Deliver Improved Access and Better Engagement with Tested and Evidence-Based Strategies (PREVENT DIABETES) Act. This would enable Medicare coverage of connected health services in the Medicare Diabetes Prevention Program. Read more
A new analysis of the Vitamin D and Type 2 Diabetes (D2d) study says that a daily supplementation of 100 μg (4,000 units) of vitamin D3, which would increase blood levels of vitamin D to higher levels than those considered adequate for bone health, may decrease the risk of type 2 diabetes in adults with […]
Researchers investigating how diabetes affects the results of total knee arthroplasty, or knee replacement, looked at physical activity, pain, impairments, and quality of life in knee replacement patients with and without diabetes. They found that people with diabetes had poorer outcomes. Read more
The widely used type 2 diabetes drug metformin is often associated with lactic acidosis, especially in patients with kidney disease. However, a new study suggests this may not the case for patients with mild to moderate kidney disease. Read more
Researchers are gaining insight into the biochemical pathway around a protein called Parkin, which plays a key role in maintaining cellular energy. When the Parkin protein misfunctions, it can contribute to the development of Parkinson’s disease, type 2 diabetes, and cancer. Read more
A study of the diabetes drug canagliflozin (Invokana) found that it was able to steadily reduce the risk of death and hospitalizations due to heart failure in patients with both type 2 diabetes and chronic kidney disease. Read more
A large study that tested whether AstraZeneca’s diabetes drug Farxiga showed benefit in treating patients hospitalized with COVID-19 and at risk of developing serious complications did not meet its goals. Read more
Exercise is essential for people with diabetes, but it also can contribute to variations in blood sugar levels, depending on the type of exercise, duration, and many other factors. A small pilot study suggests that low insulin with modest hyperglycemia may be better than higher insulin levels when exercising with type 1 diabetes. Read more
The U.S. Food and Drug Administration (FDA) grants its Breakthrough Therapy designation to new drugs that show promise, to speed up the drugs’ development and review. A new type 1 diabetes drug, vTv Therapeutics’ TTP399, which is being developed as an adjunctive therapy to insulin for type 1 diabetes, has been granted this designation. Read […]
People with diabetes are at increased risk for chronic kidney disease (CKD), especially as they grow older, and the prevalence of CKD increases further when people with diabetes also have cardiovascular disease. Medical and lifestyle interventions to reduce cardiovascular risk factors can also help reduce the risk or progression of CKD. Read more
A recently published expert overview examines the cardiovascular benefits and risks of common diabetes drugs currently available in the United States, and lists which newer drug classes are beneficial for diabetes patients who already have indications of heart or blood vessel disease. Read more